Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: A bone histomorphometry study

Journal of Nutritional Science and Vitaminology

Volumn 52, Issue 5, 2006, Pages 307-315

  Iwamoto, Jun ^a   Takeda, Tsuyoshi ^a   Sato, Yoshihiro ^b   Shen, Chwan Li ^c   Yeh, James K ^d  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Mitate Hospital   (Japan)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Cancellous osteopenia; Ovariectomy; Pretreatment; Risedronate; Vitamin K2

Indexed keywords

MENATETRENONE; RISEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MASS; CANCELLOUS BONE; CONTROLLED STUDY; CORTICAL BONE; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; MAINTENANCE THERAPY; METAPHYSIS; MONOTHERAPY; MORPHOMETRICS; NONHUMAN; OSTEOLYSIS; OSTEOPENIA; OVARIECTOMY; RAT; TIBIA; TREATMENT DURATION;

ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; DENSITOMETRY, X-RAY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ETIDRONIC ACID; FEMALE; FEMUR; OVARIECTOMY; PREMEDICATION; RATS; RATS, SPRAGUE-DAWLEY; TIBIA; TIME FACTORS; TREATMENT OUTCOME; VITAMIN K 2; VITAMINS;

RATTUS;

EID: 33846118450     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.52.307     Document Type: Article

References (44)

1. Fogelman I, Ribot C, Smith R, Ethgen D, Sod E, Reginster JY. 2000. Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 85: 1895-1900.
2. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH III, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD. 1999. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. JAMA 282: 1344-1352.
3. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY. 2001. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344: 333-340.
4. 2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 15: 515-521.
5. Ishida Y, Kawai S. 2004. Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi osteoporosis prevention study. Am J Med 117: 549-555.
6. 2 and bisphosphonate in postmenopausal women with osteoporosis. Yonsei Med J 44: 751-756.
7. 3. J Bone Miner Res 17: 1498-1511.
8. 2. J Bone Miner Metab 22: 404-414.
9. Mellstrom DD, Sorensen OH, Goemaere S, Roux C, Johnson TD, Chines AA. 2004. Seven years of treatment with risedronate in women with postmenopausal osteoporosis. Calcif Tissue Int 75: 462-468.
10. 2 (menatetrenone) on bone resorption in ovariectomized rats: a histomorphometric and dual energy X-ray absorptiometric study. Jpn J Pharmacol 80: 67-74.
11. Asawa Y, Amizuka N, Hara K, Kobayashi M, Aita M, Li M, Kenmotsu S, Oda K, Akiyama Y, Ozawa H. 2004. Histochemical evaluation for the biological effect of menatetrenone on metaphyseal trabeculae of ovariectomized rats. Bone 35: 870-880.
12. 2 on three-dimensional trabecular microarchitecture in ovariectomized rats. J Bone Miner Res 15: 1810-1817.
13. 2 on lumbar vertebral bone: histomorphometric analyses in experimental osteoporotic rats. J Orthop Sci 6: 535-559.
14. Khan AA, Syed Z. 2004. Bone densitometry in premenopausal women: synthesis and review. J Clin Densitom 7: 85-92.
15. Gambacciani M, Spinetti A, Taponeco F, Cappagli B, Maffei S, Manetti P, Piaggesi L, Fioretti P. 1994. Bone loss in perimenopausal women: a longitudinal study Maturitas 18: 191-197.
16. Lin BY, Lee WS, Ma YF, Ke HZ, Kimmel DB, Li XJ. 1994. Effects of prostaglandin E2 and risedronate administration on cancellous bone in older female rats. Bone 15: 489-496.
17. Mosekilde L, Thomsen JS, Mackey MS, Phipps RJ. 2000. Treatment with risedronate or alendronate prevents hind-limb immobilization-induced loss of bone density and strength in adult female rats. Bone 27: 639-645.
18. Shiraishi A, Higashi S, Masaki T, Saito M, Ito M, Ikeda S, Nakamura T. 2002. A comparison of alfacalcidol and menatetrenone for the treatment of bone loss on an ovaricetomized rat model of osteoporosis. Calcif Tissue Int 71: 69-79.
19. Erben RG. 1997. Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry. J Histochem Cytochem 45: 307-313.
20. Prakasam G, Yeh JK, Chen MM, Castro-Magana M, Liang CT, Aloia JF. 1999. Effects of growth hormone and testosterone on cortical bone formation and bone density in aged orchiectomized rats. Bone 24: 491-497.
21. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASMBR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595-610.
22. Fleisch H. 1998. Bisphosphonates: Mechanism of action. Endocr Rev 19: 80-100.
23. Hauschka PV, Lian JB, Cole DEC, Gundberg CM. 1989. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 69: 990-1047.
24. 2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res 12: 431-438.
25. Shearer MJ. 1995. Vitamin K. Lancet 345: 229-234.
26. Vermeer C, Jie KSG, Knapen MHJ. 1995. Role of vitamin K in bone metabolism. Annu Rev Nutr 15: 1-22.
27. 2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem 278: 43919-43927.
28. 2 inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures. Bone 27: 769-776.
29. 2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem Biophys Res Commun 220: 515-519.
30. 2 (menatetrenone) on bone resorption may be related to its side chain. Bone 16: 179-184.
31. 2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats. J Bone Miner Res 18: 776-783.
32. Hara K, Akiyama Y, Ohkawa T, Tajima T. 1993. Effects of menatetrenone on prednisolone-induced bone loss in rats. Bone 14: 813-818.
33. 2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats. Bone 31: 575-581.
34. Iwasaki Y, Yamato H, Murayama H, Takahashi T, Ezawa I, Kurokawa K, Fukagawa M. 2002. Menatetrenone prevents osteoblast dysfunction in unilateral sciatic neurectomized rats. Jpn Pharmacol 90: 88-95.
35. Iwasaki-Ishizuka Y, Yamato H, Murayama H, Abe M. Takahashi K, Kurokawa K, Fukagawa M, Ezawa I. 2003. Menatetrenone ameliorates reduction in bone mineral density and bone strength in sciatic neurectomized rats. J Nutr Sci Vitaminol 49: 256-261.
36. 2 in mature rats with long-term tail suspension. J Bone Miner Metab 20: 216-222.
37. Kato S, Mano T, Kobayashi T, Yamazaki N, Himeno Y, Yamamoto K, Itoh M, Harada N, Nagasaka A. 2002. A calcium-deficient diet caused decreased bone mineral density and secondary elevation of estrogen in aged male rats-effect of menatetrenone and elcatonin. Metabolism 51: 1230-1234.
38. Iwamoto J, Yeh JK, Takeda T, Ichimura S, Sato Y. 2003. Comparative effect of vitamin K and vitamin D supplementation on prevention of osteopenia in calcium-deficient young rats. Bone 33: 557-566.
39. 2 (menatetrenone) on calcium balance in ovariectomized rats. Jpn J Pharmacol 88: 55-61.
40. 2) on bone mineral density and bone strength in Ca/Mg deficient rats. Nippon Yakurigaku Zasshi 120: 195-204 (in Japanese).
41. 2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet. Bone 35: 1136-1143.
42. Yamaura M, Nakamura T, Tsurukami H, Hijioka A, Narusawa K, Ohnishi H, Ohta T, Hosoda K. 1996. Local bone turnover in the metaphysis of the proximal tibia and the lumbar vertebra during the early periods after ovariectomy in rats. Calcif Tissue Int 58: 52-59.
43. 2 further increases bone volume and ameliorates extremely low turnover bone induced by bisphosphonate therapy in tail-suspension rats. J Bone Miner Metab 21: 154-160.
44. 2001. NIH consensus development panel on osteoporosis prevention. Diagnosis and Therapy. JAMA 285: 785-795.